These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36801614)

  • 1. Induction of filamin-C and its involvement in the regulation of cellular senescence and apoptosis in Huh-7 hepatoma cells during arsenic trioxide exposure.
    Aki T; Kukita M; Takata M; Funakoshi T; Unuma K; Uemura K
    Biochem Biophys Res Commun; 2023 Apr; 651():92-97. PubMed ID: 36801614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Cell Autophagy on the Apoptosis of Hepatocellular Carcinoma Cells Induced by Arsenic Trioxide].
    Li Y; Gu SY; Zhang ZZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):186-190. PubMed ID: 28612524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Luo Q; Li Y; Deng J; Zhang Z
    Chem Biol Interact; 2015 Jan; 226():12-22. PubMed ID: 25499136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
    Chaudhary A; Bhardwaj SK; Khan A; Srivastava A; Sinha KK; Ali M; Haque R
    Biol Trace Elem Res; 2023 Jul; 201(7):3300-3310. PubMed ID: 36192614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment.
    Xu Y; Gu X; Gong M; Guo G; Han K; An R
    Cancer Biol Ther; 2013 Oct; 14(10):897-906. PubMed ID: 23917726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
    Rangwala F; Williams KP; Smith GR; Thomas Z; Allensworth JL; Lyerly HK; Diehl AM; Morse MA; Devi GR
    BMC Cancer; 2012 Sep; 12():402. PubMed ID: 22963400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide preferentially induces nonapoptotic cell deaths as well as actin cytoskeleton rearrangement in the CHO AA8 cell line.
    Izdebska M; Klimaszewska-Wiśniewska A; Lewandowski D; Marcin Nowak J; Gagat M; Grzanka A
    Postepy Hig Med Dosw (Online); 2014 Dec; 68():1492-500. PubMed ID: 25531713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L; Zhang G; Lou Z; Xu G; Zhang G
    BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
    Wu X; Shi J; Wu Y; Tao Y; Hou J; Meng X; Hu X; Han Y; Jiang W; Tang S; Zangari M; Tricot G; Zhan F
    Cancer Biol Ther; 2010 Dec; 10(11):1201-14. PubMed ID: 20953137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma.
    Matulis SM; Morales AA; Yehiayan L; Lee KP; Cai Y; Boise LH
    PLoS One; 2012; 7(12):e52662. PubMed ID: 23285138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
    Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 hijacks the arsenic trioxide resistance in SH-SY5Y cells.
    Wang J; Peng X; Yang D; Guo M; Xu X; Yin F; Wang Y; Huang J; Zhan L; Qi Z
    J Cell Mol Med; 2022 Jan; 26(2):563-569. PubMed ID: 34910369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
    Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
    Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
    Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I
    PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
    Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
    Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.